Evidence map›Paper›PMID 28179190›Full record

ArticleDevelopmental biology2017

Species-specific developmental timing is maintained by pluripotent stem cells ex utero.

Christopher Barry, Matthew T Schmitz, Peng Jiang, Michael P Schwartz, Bret M Duffin, Scott Swanson, Rhonda Bacher, Jennifer M Bolin, Angela L Elwell, Brian E McIntosh and 2 more

Abstract read
In one paragraph

Article in Developmental biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The past, present, and future promise of pluripotent stem cells.Journal of immunology and regenerative medicine · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Christopher BarryMorgridge Institute for Research, Madison, WI 53715, USA.
Matthew T SchmitzMorgridge Institute for Research, Madison, WI 53715, USA.
Peng JiangMorgridge Institute for Research, Madison, WI 53715, USA.
Michael P SchwartzCenter for Sustainable Nanotechnology, Department of Chemistry, University of Wisconsin-Madison, WI 53706, USA.
Bret M DuffinMorgridge Institute for Research, Madison, WI 53715, USA.
Scott SwansonMorgridge Institute for Research, Madison, WI 53715, USA.
Rhonda BacherDepartment of Statistics, University of Wisconsin-Madison, WI 53706, USA.
Jennifer M BolinMorgridge Institute for Research, Madison, WI 53715, USA.
Angela L ElwellMorgridge Institute for Research, Madison, WI 53715, USA.
Brian E McIntoshMorgridge Institute for Research, Madison, WI 53715, USA.
Ron StewartMorgridge Institute for Research, Madison, WI 53715, USA.
James A ThomsonMorgridge Institute for Research, Madison, WI 53715, USA; Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA; Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA 93106, USA. Electronic address: jthomson@morgridge.org.
Morgridge Institute for Research · USUniversity of Wisconsin–Madison · US

Funding

Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and TeratogenicityUH2TR000506 · NCATS · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI THOMSON, JAMES ALEXANDER · 2012 to 2013
$2.4M
Interdisciplinary Training Program in Cardiovascular and Pulmonary BiostatisticsT32HL083806 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI RATHOUZ, PAUL JOSEPH · 2006 to 2015
$1.8M
CIHR BPF-112938NCATS NIH HHS UH2 TR000506NHLBI NIH HHS T32 HL083806
6 · The paper itself

Abstract

How species-specific developmental timing is controlled is largely unknown. By following human embryonic stem (ES) cell and mouse epiblast stem (EpiS) cell differentiation through detailed RNA-sequencing time courses, here we show that pluripotent stem cells closely retain in vivo species-specific developmental timing in vitro. In identical neural differentiation conditions in vitro, gene expression profiles are accelerated in mouse EpiS cells compared to human ES cells with relative rates of differentiation closely reflecting the rates of progression through the Carnegie stages in utero. Dynamic Time Warping analysis identified 3389 genes that were regulated more quickly in mouse EpiS cells and identified none that were regulated more quickly in human ES cells. Interestingly, we also find that human ES cells differentiated in teratomas maintain the same rate of differentiation observed in vitro in spite of being grown in a mouse host. These results suggest the existence of a cell autonomous, species-specific developmental clock that pluripotent stem cells maintain even out of context of an intact embryo.

Indexed as

AnimalsCell DifferentiationCell LineEmbryonic Stem CellsFemaleGene Expression ProfilingGene Expression RegulationHumansMice, SCIDNeuronsPluripotent Stem CellsSpecies SpecificityTeratomaTime FactorsBrain developmentDevelopmental timeDifferentiationEmbryonic stem cells

Identifiers

PMID28179190
PMCPMC5384572
OpenAlexW2587704576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.